ProCE Banner Activity

My Take on Viral Hepatitis Treatment Advances From AASLD 2022: European Perspective

Conference Coverage
Clinical Thought

There were many exciting developments in viral hepatitis presented at AASLD 2022, which makes me look forward to guideline updates to reflect evolving screening and therapeutic recommendations for HBV, HCV, and HDV.

Released: December 05, 2022

Share

Faculty

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Stefan Zeuzem, MD: consultant/advisor/speaker: AbbVie, BioMarin, Gilead Sciences, GlaxoSmithKline, Intercept, Janssen, MSD/Merck, Novo Nordisk, SoBi.